Attention Y-mAbs Investors: Important Class Action Lawsuit Update from Kaplan Fox Kilsheimer LLP
Kaplan Fox & Kilsheimer LLP Investigates Claims on Behalf of Y-mAbs Investors NEW YORK, Jan. 19, 2023 (GLOBE NEWSWIRE) — Kaplan Fox & Kilsheimer LLP is continuing its investigation of claims on behalf of investors in Y-mAbs Therapeutics, Inc. (“Y-mAbs” or the “Company”) (NASDAQ: YMAB) stock. A complaint has been filed on behalf of investors…